NPI: 1366981268 · RIVERVIEW, FL 33578 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/13/2017
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (SR DIRECTOR LICENSURE&CERTIFICATION) |
| NPI Enumeration Date | 02/13/2017 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 6,758 | $1.06M |
| 2020 | 22,717 | $2.66M |
| 2021 | 20,763 | $1.55M |
| 2022 | 12,410 | $934K |
| 2023 | 3,994 | $387K |
| 2024 | 425 | $14K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 24,313 | 1,542 | $2.58M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 19,467 | 1,087 | $1.81M |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,006 | 629 | $709K |
| A4657 | Syringe, with or without needle, each | 3,525 | 1,067 | $526K |
| J1756 | Injection, iron sucrose, 1 mg | 4,369 | 813 | $352K |
| 85048 | 1,054 | 630 | $108K | |
| 85041 | 1,057 | 631 | $108K | |
| 83970 | 967 | 556 | $96K | |
| 82728 | 850 | 467 | $84K | |
| 83540 | 886 | 486 | $83K | |
| 83550 | 881 | 480 | $80K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 608 | 279 | $56K |
| G0008 | Administration of influenza virus vaccine | 36 | 26 | $4K |
| 90674 | 19 | 13 | $3K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 29 | 12 | $429.57 |